This compound is primarily used in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of compounds that target central nervous system disorders, including antidepressants and anxiolytics. Its trifluoromethyl group enhances the biological activity and metabolic stability of the resulting drugs, making it valuable in medicinal chemistry. Additionally, it is utilized in the study of receptor binding and enzyme inhibition, aiding in the discovery of new therapeutic agents. Its application extends to the development of novel compounds for treating neurological and psychiatric conditions.